|
6661 |
Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients—a randomized rater-blinded trial
Enthalten in Trials Bd. 25, 9.4.2024, Nr. 1, date:12.2024: 1-12
|
|
|
|
6662 |
Validity of different biomonitoring parameters for the assessment of occupational exposure to N,N-dimethylformamide (DMF)
Enthalten in Archives of toxicology Bd. 92, 10.5.2018, Nr. 7, date:7.2018: 2183-2193
|
|
|
|
6663 |
Value of Ultrasound (US)-Guided Percutaneous Needle Biopsy of Detected Pathological Gastrointestinal (GI) Tract Lesions but Negative or Incomplete Endoscopy
Enthalten in Ultraschall in der Medizin Bd. 32, 2011, Nr. S 02: E14-E19
|
|
|
|
6664 |
Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countries
Enthalten in BMC geriatrics Bd. 17, 20.4.2017, Nr. 1, date:12.2017: 1-7
|
|
|
|
6665 |
Variation in wood density across South American tropical forests
Enthalten in Nature Communications Bd. 16, 10.3.2025, Nr. 1, date:12.2025: 1-12
|
|
|
|
6666 |
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Enthalten in BMC gastroenterology Bd. 18, 15.9.2018, Nr. 1, date:12.2018: 1-7
|
|
|
|
6667 |
Venetoclax bei r/rMM eher ungeeignet
Enthalten in InFo Hämatologie + Onkologie Bd. 28, 11.9.2025, Nr. 9, date:9.2025: 32
|
|
|
|
6668 |
Venetoclax-Monotherapie lohnt sich nach CLL-Rezidiv
Enthalten in Im Focus Onkologie Bd. 27, 24.10.2024, Nr. 5, date:10.2024: 14
|
|
|
|
6669 |
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
Enthalten in Experimental hematology & oncology Bd. 8, 16.4.2019, Nr. 1, date:12.2019: 1-5
|
|
|
|
6670 |
VennMaster: Area-proportional Euler diagrams for functional GO analysis of microarrays
Enthalten in BMC bioinformatics Bd. 9, 29.1.2008, Nr. 1, date:12.2008: 1-12
|
|
Administration
